Chapman Steven Leonard sold $528K of NTRA
Chapman Steven Leonard (CEO AND PRESIDENT) sold 2,400 shares of Natera, Inc. (NTRA) at $220.19 ($0.53M total) on 2026-06-04 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
Because the sale is explicitly pre-arranged, it is generally treated as lower informational content than unscheduled selling; the main tradable angle is short-term sentiment around insider activity.
Market read
Insider selling disclosure for NTRA (10b5-1) with modest sentiment relevance and limited fundamental implications.
What to watch
The disclosure does not indicate whether the sale was part of a larger scheduled program cadence, nor does it provide context on total holdings changes beyond the post-transaction figure.
Background
The article is an SEC Form 4 insider transaction: CEO/President Chapman Steven Leonard sold shares of Natera on an open-market basis under a pre-arranged Rule 10b5-1 plan.
Ticker impact
Natera CEO and President Chapman Steven Leonard sold 2,400 shares in an open-market transaction disclosed on SEC Form 4.
Likely limited near-term impact; any move would be sentiment-driven rather than fundamental.
The filing specifies a pre-arranged 10b5-1 plan, reducing the likelihood the sale reflects new negative information.
Market effects
No clear read-across to the broader biotech/diagnostics sector from a single 10b5-1 insider sale.
None indicated.
None indicated.
Counterpoint
Even with a 10b5-1 plan, repeated insider selling can still be interpreted by some traders as a lack of conviction, especially if it coincides with other negative signals.
Key entities
- public_companyNatera, Inc.
Issuer of the SEC Form 4 insider transaction; CEO/President sold 2,400 shares at $220.1875.
- insiderChapman Steven Leonard
CEO and President who executed the open-market sale under a 10b5-1 plan.
